SIRT3‐dependent deacetylation exacerbates acetaminophen hepatotoxicity by Lu, Zhongping et al.
SIRT3-dependent deacetylation exacerbates
acetaminophen hepatotoxicity
Zhongping Lu1, Mohammed Bourdi2, Jian H. Li1, Angel M. Aponte3, Yong Chen3, David B. Lombard4,
Marjan Gucek3, Lance R. Pohl2 & Michael N. Sack1+
1Center for Molecular Medicine, NHLBI, 2Molecular and Cellular Toxicology Section, Laboratory of Molecular Immunology, NHLBI,
3Proteomic Core Facility, NHLBI, Bethesda, Maryland, and 4Department of Pathology and Institute of Gerontology, University of
Michigan, Ann Arbor, Michigan, USA
Acetaminophen/paracetamol-induced liver failure—which is in-
duced by the binding of reactive metabolites to mitochondrial
proteins and their disruption—is exacerbated by fasting. As
fasting promotes SIRT3-mediated mitochondrial-protein de-
acetylation and acetaminophen metabolites bind to lysine
residues, we investigated whether deacetylation predisposes mice
to toxic metabolite-mediated disruption of mitochondrial pro-
teins. We show that mitochondrial deacetylase SIRT3/mice are
protected from acetaminophen hepatotoxicity, that mitochon-
drial aldehyde dehydrogenase 2 is a direct SIRT3 substrate, and
that its deacetylation increases acetaminophen toxic-metabolite
binding and enzyme inactivation. Thus, protein deacetylation
enhances xenobiotic liver injury by modulating the binding of
a toxic metabolite to mitochondrial proteins.
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INTRODUCTION
The acetylation of protein lysine residues is a common post-
translational modification (Kim et al, 2006; Zhao et al, 2010). In
the liver, mitochondrial proteins show nutrient-level-dependent
lysine acetylation and deacetylation (Kim et al, 2006; Schwer
et al, 2009), and the functional consequences of this being
explored. The mitochondrial-enriched deacetylase SIRT3 pro-
motes protection against redox and nutrient-excess stressors
(Yang et al, 2007; Sundaresan et al, 2008; Bao et al, 2010; Tao
et al, 2010), and SIRT3-dependent reduction in redox-stress is
augmented by fasting or caloric restriction (Someya et al, 2010;
Tao et al, 2010).
In the light of these nutrient-restricted SIRT3 antioxidant effects,
an interesting paradox exists: fasting or caloric restriction
exacerbate redox-stress-dependent toxicity of the analgesic agent
acetaminophen (N-acetyl-p-aminophenol or APAP; Whitcomb &
Block, 1994; Fernando & Ariyananda, 2009). APAP is the most
common drug-induced cause of acute liver failure (Hutson, 2010);
the APAP toxic metabolite, N-acetyl-p-benzoquinoneimine (NAP-
QI) depletes hepatic glutathione in a dose-dependent manner
(James et al, 2003; Jaeschke & Bajt, 2006). Unconjugated NAPQI
then binds to cysteine residues causing oxidative stress, mitochon-
drial disruption and hepatotoxicity (Ruepp et al, 2002; Kon et al,
2004). Although there is N-acetylcysteine therapy, mortality from
APAP-induced liver failure is not uncommon (Lai et al, 2006)
and alternative therapies are being investigated (North et al,
2010). Although NAPQI also binds to hepatic-protein lysine
residues (Zhou et al, 1996), the functional significance of
this interaction is unknown. As lysine acetylation might partly
function by competing with alternative post-translational modi-
fications, targeting the same residue (Yang & Seto, 2008), the
paradox regarding fasting and redox stress in the context of
acetaminophen-induced liver injury (AILI) might be due, in part, to
protein lysine residue deacetylation-mediated susceptibility to
NAPQI binding.
We hypothesized that if protein acetylation allosterically
inhibits NAPQI binding, SIRT3-mediated deacetylation might
exacerbate hepatotoxicity, despite the protective role of SIRT3
against redox-stress.
RESULTS
The absence of SIRT3 protects against AILI
We administered a toxic dose of APAP to SIRT3þ /þ and SIRT3/
mice in fed and fasted conditions. Baseline serum alanine
transaminase (ALT) levels were indistinguishable between geno-
types, and similar ALT release was seen in fed mice, irrespective of
their genotype (Fig 1A). As expected, fasting increased suscepti-
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bility to AILI (Fig 1A). However, in contrast to the fed mice, the
fasted SIRT3/ mice showed less hepatotoxicity, as shown by ALT
release and less centrilobular coagulative necrosis—compared with
the SIRT3 competent mice—in response to APAP administration
(Fig 1A–C). This difference in fasting hepatotoxic susceptibility
between the SIRT3þ /þ and SIRT3/ mice is not because of the
differential rate of depletion of glutathione, as the levels of gluta-
thione are similar following the overnight fast in the two genotypes,
and are similarly depleted 4 h after APAP administration (Fig 1D).
Identification of putative targets for SIRT3-mediated AILI
To identify new mitochondrial-protein acetylation targets that
might orchestrate the protective effects against AILI, we screened
for candidate proteins that could potentially mediate this effect, by
comparing hepatic mitochondrial-protein acetylation profiles
between fasted SIRT3/ and SIRT3þ /þ mice. Two-dimensional
gel and immunoblot analysis with an antibody recognizing
acetylated lysine were used. Differentially acetylated spots were
isolated, and sequenced by tandem mass spectrometry (MS/MS).
We identified 17 proteins that reproducibly showed increased
lysine acetylation in the SIRT3/ compared with SIRT3þ /þ mice
(supplementary Table S1 online; supplementary Fig S1 online).
We selected aldehyde dehydrogenase 2 (ALDH2) as the index
protein, because ALDH2 is a known target of NAPQI (Landin et al,
1996; Qiu et al, 1998), NAPQI binding is associated with reduced
ALDH2 activity (Landin et al, 1996) and this dehydrogenase
functions to oxidize and detoxify aldehydes, including lipid
peroxidation products such as trans-4-hydroxy-2-nonenal (4-
HNE; Doorn et al, 2006). Increased acetylation of ALDH2 in
SIRT3/ liver mitochondria was evident (Fig 2A). To confirm that
ALDH2 was differentially acetylated, immunoprecipitation studies
were performed using liver mitochondrial-protein lysates.
Immunoprecipitation with antibodies against ALDH2 and acety-
lated-lysine residues with reciprocal immunoblot analysis showed
that ALDH2 was more-robustly acetylated in SIRT3/ mice
(Fig 2B). This change in acetylation was associated with a direct
interaction between SIRT3 and ALDH2 by bidirectional immuno-
precipitation and immunoblot analysis using antibodies against
SIRT3 and ALDH2 (lysates from SIRTþ /þ mice; Fig 2C). We also
demonstrate in vitro deacetylation of ALDH2 in the presence of
SIRT3 and NADþ and the preservation of acetylation in
the presence of the sirtuin deacetylase inhibitor nicotinamide
(Fig 2D). Furthermore, we confirmed that fasting increased hepatic
ALDH2 deacetylation in SIRT3-competent mice (Fig 2E), and that
the SIRT5 mitochondrial deacetylase does not target ALDH2 for
deacetylation (Fig 2F).
ALDH2 activity in SIRT3/mice after APAP administration
As baseline ALDH2 activity was indistinguishable between
genotypes (Fig 3A), we evaluated whether functional effects of
ALDH2 acetylation could be revealed by measuring enzyme
activity and consequences of enzymatic action in response to
APAP toxicity in fasted mice. A reduction in mitochondrial
ALDH2 activity at 1 and 4 h after APAP administration was
evident in both genotypes, although the relative activity was
sustained at approximately 40% higher levels in SIRT3/
mitochondria at both of these time points (Fig 3A). This difference
in activity was probably not due to changes in protein degrada-
tion, as steady-state ALDH2 levels were not diminished in
response to APAP (Fig 3B). To evaluate the functional con-
sequences of altered ALDH2 activity, we measured levels of lipid
peroxidation adduct-binding to mitochondrial proteins. The base-
line levels of 4-HNE in liver mitochondria were similar (supple-
mentary Fig S2 online). By contrast, 1 h after APAP exposure, the
SIRT3/ mitochondrial proteins showed lower 4-HNE-adduct
levels compared with SIRT3þ /þ mice (Fig 3C). As disruption of
mitochondrial respiration is an early indicator of APAP-induced
hepatotoxicity (Donnelly et al, 1994), we quantified mitochondrial
respiration in response to APAP and showed that oxidative
metabolism was preserved to a greater extent in the SIRT3/
compared with SIRT3þ /þ mice (supplementary Fig S3 online).
The depletion of ALDH2 counters AILI resistance
The functional requirement of ALDH2 activity in resisting APAP
toxicity in SIRT3/ mice was then interrogated using lentiviral
short-hairpin RNA (shRNA). Different shRNA viral particles
targeting ALDH2 or scrambled controls were tested in murine
liver cells and construct sh5–ALDH2 showed the most robust
knockdown (supplementary Fig S4A online). Five days after tail-
vein injection with this shALDH2 and scrambled control lentiviral
particles, liver extracts showed an approximately 50% reduction
in ALDH2 protein levels compared with scrambled shRNA-
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Fig 1 | SIRT3/ mice are less susceptible to acetaminophen-induced
liver injury than SIRT3þ /þ mice. (A) Fed and overnight-fasted mice
received a bolus of N-acetyl-p-aminophenol (APAP), and serum alanine
transaminase (ALT) activity was measured at baseline, 8 and 24 h
(Po0.05, nX7 mice per group). (B) Liver histology with haematoxylin
and eosin stain was evaluated at 24 h after APAP in fasted mice. Five
mice were analysed per group and a representative result from each
group is shown. (C) Blinded quantitation of the degree of necrosis;
higher scores reflect increased injury. The scoring system is described in
the supplementary information online. (D) Reduced glutathione (GSH)
levels 4 h after the administration of either saline or APAP in mice that
had been fasted overnight (n¼ 6 per group). Asterisk indicates a P value
o0.02, compared with the respective controls.
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control and ALDH2 shRNA-targeted SIRT3þ /þ and SIRT3/
mice. The introduction of lentiviral particles increased liver injury
in both strains compared with toxicity in the absence of virus
(compare Fig 3E with Fig 1A). The specific knockdown of ALDH2
in SIRT3/ mice increased liver injury in response to APAP, with
greater elevations in ALT levels at 8 and 24 h (Fig 3E). AILI
susceptibility was not, however, changed in SIRT3þ /þ mice (Fig
3E), indicating that the disruption of ALDH2 function by AILI in
wild-type mice cannot be perturbed further by the shRNA
depletion of ALDH2. The enhanced liver injury following ALDH2
knockdown in the SIRT3/ mice was reflected by increased
levels of 4-HNE adducts binding to mitochondrial proteins (Fig 3F)
and by exacerbation of centrilobular necrosis (supplementary
Fig S4B online).
ALDH2 acetylation modulates NAPQI binding
The possibility that a reduction in ALDH2 deacetylation could
maintain enzymatic activity in response to toxic doses of
acetaminophen has not been previously recognized. As binding
of the APAP reactive metabolite, NAPQI, to ALDH2 has
previously been associated with lower ALDH2 activity (Landin
et al, 1996), we investigated whether inhibition of sirtuin activity
could modulate NAPQI binding. Exogenous ALDH2 was ex-
pressed in murine liver cells and exposed to NAPQI in the
presence or absence of the sirtuin inhibitor nicotinamide. The
amount of NAPQI bound to ALDH2 was reduced by inhibition of
sirtuin deacetylase functioning, with a concomitant increase in
ALDH2 protein acetylation (Fig 4A). In parallel, binding
of NAPQI to ALDH2 was increased after overexpression of
deacetylase-competent SIRT3, and attenuated in the presence of
the deacetylase-mutant SIRT3, with reduced ALDH2 acetylation
correlating to the degree of NAPQI binding (Fig 4B). In parallel,
the small-interfering RNA knockdown of SIRT3 in these hepato-
cytes diminished NAPQI binding to ALDH2 (Fig 4C) and













































































Fig 2 | ALDH2 is a functional target of SIRT3. (A) Liver mitochondrial proteins isolated from SIRT3þ /þ and SIRT3/ mice were separated by
IEF/SDS two-dimensional gel electrophoresis and probed with acetylated-lysine (Ac-K) antibody. The experiment was repeated three times and
representative blots are shown. (B) Liver mitochondrial proteins from SIRT3þ /þ and SIRT3/ mice immunoprecipitated with antibodies against
Ac-K and ALDH2, with inverse immunoblot analysis to assess the degree of ALDH2 acetylation relative to the levels of hepatic SIRT3. Silver staining
of the gel showed similar input of Ac-K immunoprecipitation samples. The ALDH2 immunoblot analysis showed equal input of the samples
precipitated by ALDH2 for Ac-K immunoblot analysis. The experiment was performed three times and representative blots from a single experiment
are shown. (C) Co-immunoprecipitation with antibodies against SIRT3 and ALDH2, with dual antibody immunoblot analysis to examine the
interaction between SIRT3 and ALDH2 in protein extracted from wild-type mouse liver. The experiment was performed three times and representative
blots from a single experiment are shown. (D) Mitochondrial protein was isolated from wild-type mouse liver. SIRT3 and ALDH2 proteins were
immunoprecipitated with SIRT3 and ALDH2 antibodies and incubated in an in vitro deacetylation buffer in the presence or absence of NADþ and/or
NAM. The reaction products were probed with Ac-K antibody to determine the levels of ALDH2 acetylation in response to conditions facilitating or
inhibiting protein deacetylation. The experiment was performed three times and representative blots from a single experiment are shown. (E) Level of
acetylation of liver ALDH2 in the fed and fasted state in SIRT3þ /þ mice. The Ac-K antibody was used to immunoprecipitate mitochondrial protein,
and immunoblot analysis was performed with an antibody targeting ALDH2. The band immediately above the 51 kDa marker is ALDH2. Four mice
per group were analysed and a representative blot showing two animals from each group is shown. (F) Following co-transfection of Flag-tagged
ALDH2 and the listed sirtuin deacetylases, the exogenous ALDH2 was immunoprecipitated using a Flag antibody. Precipitant was run on gel and
immunoblotted for the Flag-tag and for Ac-K, to demonstrate the extent of ALDH2 deacetylation. (A–D,F) Experiment were performed three times and
representative blots are shown. ALDH2, aldehyde dehydrogenase 2; IEF, isoelectric focusing; IgG, immunoglobulin G; IP, immunoprecipitation; NAD,
nicotinamide adenine dinucleotide; NAM, nicotinamide; WB, western blot.
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Deacetylation of ALDH2 Lys 377 enhances NAPQI binding
To confirm that the acetyl status of lysine residues modifies NAPQI
binding to ALDH2, we identified ALDH2 lysine residues that
were deacetylated by SIRT3. Liquid chromatography-MS/MS
sequencing of acetylated lysine antibody immuno-captured
trypsin-digested peptides (Kim et al, 2006) from SIRT3þ /þ and
SIRT3/ mice mitochondria identified Lys 370 and Lys 377 as
acetylation sites that might be operational in this allosteric
modification of NAPQI binding (Fig 4E). Mutational studies were
performed to mimic deacetylation (Lys to Arg) and acetylation (Lys
to Gln), and showed that the ALDH2 Lys 377 is a principal lysine
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Fig 3 | ALDH2 function is relatively preserved in fasted SIRT3/ mice in response to APAP, and it is required to reduce acetaminophen-induced liver
injury in SIRT3/ mice. (A) Mitochondrial ALDH2 activity was measured by the change in absorbance at 340 nm, in hepatic mitochondrial protein
extracted at baseline, 1 and 4 h after APAP administration in SIRT3þ /þ and SIRT3/ mice (n¼ 6 per group). (B) Relative protein levels of hepatic
ALDH2 were evaluated by immunoblot analysis at baseline and 1 h after APAP administration comparing SIRT3þ /þ and SIRT3/ mice. Liver tissue
from four mice from each genotype was analysed at the two time points and a representative blot is shown. (C) 4-HNE adducts bound to liver
mitochondrial protein 1 h after the administration of APAP. Liver tissue from six mice in each group were analysed and a representative blot showing
three samples from each genotype are shown. (D) Immunoblot analysis of liver tissue showing ALDH2 levels following infection with shRNA targeted
against ALDH2 compared with scrambled (Scr) control shRNA. Four mice from each group were analysed and two representative samples of each
shRNA knockdown are shown. (E) Five days after administration of the scrambled compared with ALDH2 shRNA lentiviral particles, mice were
treated with APAP and ALT levels were measured at 8 and 24 h, respectively (n410 per group). (F) 4-HNE adducts bound to liver mitochondrial
protein 1 h after the administration of APAP in mice following knockdown of ALDH2. The re-emergence of 4-HNE adducts in the SIRT3/ mice
following ALDH2 knockdown are highlighted by the arrowheads on the right side of the blot. Four mice from each group were analysed and two
representative samples of each shRNA knockdown are shown. Asterisk indicates a P value o0.03, compared with the respective controls. ALDH2,
aldehyde dehydrogenase 2; ALT, serum alanine transaminase; APAP, N-acetyl-p-aminophenol; shRNA, short-hairpin RNA; VDAC, voltage-dependent
anion channel; 4-HNE, trans-4-hydroxy-2-nonenal.
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The predominant approach to ameliorate toxic effects of AILI has
focused on antioxidant pathways on the basis of NAPQI binding to
cysteine residues (Nelson, 1990; Qiu et al, 1998). Even though
NAPQI binds to lysine residues (Zhou et al, 1996), the functional
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Fig 4 | The retention of ALDH2 acetylation after SIRT3 inactivation reduces NAPQI adduct binding to ALDH2. (A) Hepa-1c1c7 cells were transfected
with pCMV6-Flag control vector or pCMV6–ALDH2-Flag. After 48 h, NAPQI (200mM) and either nicotinamide (5 mM) or vehicle were administered. After
1 h incubation, the Flag-tagged ALDH2 construct was extracted by immunoprecipitation. The immunoprecipitate was run on SDS–polyacrylamide gel
electrophoresis gel and immunoblot analysis was performed with antibodies against APAP adducts, acetylated lysine and the Flag-tag. This experiment was
repeated three times in duplicate, and a representative experiment is shown. (B) Similar studies were performed with the additional introduction of either
wild-type or deacetylase-mutant SIRT3 construct. This experiment was repeated three times and a representative experiment is shown. (C) Levels of NAPQI
binding following SIRT3 depletion by siRNA. This experiment was repeated three times and a representative experiment is shown. (D) The overexpression
of SIRT5 does not modify NAPQI adduct binding. Duplicate sample experiments were repeated three times to confirm the reproducibility of interactions.
This experiment was repeated three times and a representative experiment is shown. (E) ALDH2 K377 containing peptide ILGYIKSGQQEGAK (precursor
m/z 767.4210, 5 p.p.m. mass error) was detected to be acetylated in SIRT3/ mice mitochondria by liquid chromatography MS/MS after acetyl-lysine
antibody enrichment. Shifts in fragment masses confirmed that K377 was the acetylation site within the peptide. Using a label-free quantitation approach,
the acetylation level of K377 was shown to increase 2.5-fold in SIRT3/ mice, compared with SIRT3þ /þ mice. This experiment was repeated twice and a
representative spectrum of the peptide containing K377 is shown. (F) Mutagenesis studies showing that the substitution of basic lysine (K) with a non-
polar glutamine (Q) to mimic acetylation diminishes NAPQI binding when substituted on K377, but not on K370. The arginine (R) substitution that
mimics the deacetylated state does not alter NAPQI binding. This experiment was repeated three times and a representative experiment is shown. To
prevent the luminescent emission from the secondary antibody binding to the IgG heavy chain from overwhelming the signal of the APAP adducts
binding to ALDH2 (452 kDa), the IgG signal was blocked below approximately 50 kDa. The residual signal at the bottom of the adduct gels in panels A–D
and F reflect this intervention. ALDH2, aldehyde dehydrogenase 2; APAP, N-acetyl-p-aminophenol; HA, haemagglutinin; IgG, immunoglobulin G;
IP, immunoprecipitation; MS, mass spectrometry; NAM, nicotinamide; NAPQI, N-acetyl-p-benzoquinoneimine; siRNA, small-interfering RNA;
WT, wild type.
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explored. This study investigates whether occupancy of lysine by
acetyl groups modifies NAPQI binding, and assesses whether
lysine acetylation ameliorates APAP hepatotoxic pathophysiology.
Our findings support the hypothesis that maintenance of lysine
acetylation attenuates competing metabolites targeting the same
residue (Yang & Seto, 2008), and advances this to include
retardation of NAPQI binding.
The temporal sequence of APAP-induced toxicity is well
established; adduct binding and glutathione depletion occur
within the first few hours, followed by the release of liver
enzymes, and cell death over the next 8–48 h (Roberts et al, 1991;
Hinson et al, 2004). The role of fasting-induced SIRT3 lysine
residue deacetylation in increasing NAPQI binding to ALDH2 in
the early phase of hepatotoxicity after an acute toxic dose of APAP
is shown in this study. The consequences of this toxicity are
illustrated by the exacerbation of liver injury 24 h later in
wild-type compared with SIRT3-null mice.
These data do not dismiss the role of glutathione depletion in
APAP toxicity, as evidenced by greater injury in both genotypes
when comparing fasted with fed mice. Instead this study expands
our understanding of the pathophysiology of APAP toxicity by
uncovering a new functional role for ALDH2 in attenuating
acetaminophen hepatotoxicity, and identifying the role of
acetylation in altering NAPQI binding to mitochondrial proteins.
Also, although the knockdown of ALDH2 nullifies the ameliora-
tive effects of SIRT3 deficiency in this pathophysiology, our data
cannot exclude the role of the other SIRT3 mitochondrial targets
identified in this (supplementary Table S1 online) and other
studies. Characterization of these additional SIRT3 targets in this
toxicity warrants further investigation. Interestingly, reactive
metabolites of halothane, which are also hepatotoxic, similarly
bind to lysine residues (Zhou et al, 1996; Bourdi et al, 2001).
Whether the concept of toxic metabolite binding to lysine has
broader implications in xenobiotic-mediated hepatic injury should
also be explored.
Finally, this study has not only identified ALDH2 as a new SIRT3
target, but also shows that the allosteric binding of the acetamino-
phen toxic metabolite to ALDH2 is controlled by the acetylation
status of this dehydrogenase. This nutrient-dependent function
of SIRT3 identifies a unique mediator of stress-susceptibility in
response to a xenobiotic metabolite, that is distinct from the
antioxidant effect of SIRT3, previously shown in the activation of
manganese superoxide dismutase by deacetylation (Tao et al, 2010).
In conclusion, the SIRT3-dependent acetylation status of
mitochondrial proteins modulates susceptibility to AILI.
Mitochondrial ALDH2 is identified as a new functional substrate
of SIRT3 deacetylation that has an important detoxifying role in
modulating APAP toxicity, and the acetylation of ALDH2 at
position Lys 377 modifies the amount of NAPQI binding. The
manipulation of mitochondrial protein acetylation is a new
concept to investigate in the search for strategies to reduce
acetaminophen hepatotoxicity.
METHODS
Detailed experimental procedures are described in the supple-
mentary information online.
Animal studies. The inbred C57BL/6 SIRT3þ / mice were studied
and a heterozygous breeding scheme was used. APAP was
administered in a single toxic dose (350 mg/kg, by intraperitoneal
injection) to either fed or overnight-fasted mice. All animal
experiments were approved by the NHLBI Animal Care and
Use Committee.
Lentiviral shRNA preparation and mice injection. Lentiviruses
were produced encoding a non-targeting control sequence or
constructs encoding mouse ALDH2 shRNA sequences. Mice were
subjected to tail-vein injections with control or shRNA lenti-
virus (1.2 1011 particles). ALDH2 knockdown was confirmed
and APAP was subsequently administered to fasting mice. ALT
measurement and liver histology were then analysed.
NAPQI-binding studies. pCMV6–ALDH2–Flag plasmid was
transfected into Hepa-1c1c7 cells. To evaluate the role of SIRT3
deacetylase, the wild type (hSIRT3–Flag), the deacetylase cata-
lytically inactive constructs (hSIRT3–H248Y–HA) or mSIRT5–
3xFlag were overexpressed. Cells were then treated with NAPQI
(200 mM) and nicotinamide (5 mM) or vehicle control. Immuno-
precipitation using a Flag antibody to extract the ALDH2 was
performed and run on SDS–polyacrylamide gel electrophoresis
gels. APAP metabolite binding to ALDH2 was detected by
immunoblot analysis with an antibody to NAPQI protein adducts.
Statistical analysis. Differences between data groups were
evaluated for significance using the two-tailed Student’s t-test.
Multiple comparison analysis was performed using analysis
of variance. Statistical analysis was performed using Graphpad
Prism, and data are expressed as mean±s.e.m. Po0.05 is
considered to be statistically significant.
Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
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